INOVOTION will be at BioTrinity 2016 « Europe’s Leading Investment and Biopartnering Conference », organized April 25-27th in London.
This major biotech partnering event is particular in two ways. Firstly, it will be the 10th anniversary of this event and secondly INOVOTION was invited to participate in two new showcases: the « Perfect Pitch » and the « VIP Investor and CEO Networking Lunch ».
Thanks to this congress, INOVOTION will present its « Unique In Vivo Assay For Your Oncology Drug Candidates », including Efficacy & Toxicity Evaluation and Target Validation.
With more than 1,500 participants, including Global Pharma/MedTech corporates, biotech companies and investors, this event will be a great opportunity to discuss further about drug development in oncology and how to decrease your risk in preclinical trials.
Contact us for more details about how to decrease the risk in preclinical phases!
